Rahimi Shahrzad, Angaji Seyyed Abdolhamid, Majd Ahmad, Hatami Behzad, Baghaei Kaveh
Department of Genetic, North Tehran Branch, Islamic Azad University, Tehran, Iran.
Department of Cell and Molecular Biology, Faculty of Biological Science, Kharazmi University, Tehran, Iran.
Gastroenterol Hepatol Bed Bench. 2022;15(4):406-414. doi: 10.22037/ghfbb.v15i4.2593.
This study aimed to perform a head-to-head comparison of changes during NASH progression throughout 6-11 weeks of an experiment to supply a faster nutritional model in mimicking NASH to decrease the duration and cost of in vivo studies.
New therapies are urgently needed because of the growing prevalence of non-alcoholic steatohepatitis (NASH) and the lack of an effective treatment approach. Currently, dietary interventions are the most efficient options.
This study compared features of NASH in a murine model using protocol that combined special nutritional regimes based on the combination of 21.1% fat, 41% sucrose, and 1.25% cholesterol with weekly intraperitoneal injections of carbon tetrachloride (CCl4). Male C57BL/6J mice received either special compositions + CCl4 (NASH group) or standard chow diet (healthy control group) for 11 weeks. Liver histopathology based on hematoxylin and eosin (H&E) and Masson's Trichrome (TC) staining and biochemical analyses were used to assess disease progression.
In C57BL/6J mice administered a high fat, high cholesterol, high sucrose diet and CCl4 for 8 weeks, steatohepatitis with pronounced hepatocyte ballooning, inflammation, steatosis, and fibrosis was observed. According to the NAFLD activity scoring system, the maximum NAS score was manifested after 8-9 weeks (NAS score: 6.75). Following this protocol also led to a significant increase in AST and ALT, total cholesterol, and total triglyceride serum levels in the NASH group.
Following the special nutritional regime based on high fat, cholesterol, and sucrose in combination with CCL4 injections resulted in a NASH model using C57BL/6J mice in a shorter time compared to similar studies. The obtained histopathological NASH features can be advantageous for preclinical drug testing.
本研究旨在对实验6 - 11周期间非酒精性脂肪性肝炎(NASH)进展过程中的变化进行直接比较,以提供一种更快的模拟NASH的营养模型,从而缩短体内研究的时间并降低成本。
由于非酒精性脂肪性肝炎(NASH)的患病率不断上升且缺乏有效的治疗方法,迫切需要新的治疗方法。目前,饮食干预是最有效的选择。
本研究使用一种方案比较了小鼠模型中NASH的特征,该方案将基于21.1%脂肪、41%蔗糖和1.25%胆固醇的特殊营养方案与每周腹腔注射四氯化碳(CCl4)相结合。雄性C57BL/6J小鼠接受特殊成分 + CCl4(NASH组)或标准饲料(健康对照组)喂养11周。基于苏木精和伊红(H&E)以及Masson三色染色(TC)的肝脏组织病理学检查和生化分析用于评估疾病进展。
在给予高脂肪、高胆固醇、高蔗糖饮食和CCl4的C57BL/6J小鼠中,8周后观察到伴有明显肝细胞气球样变、炎症、脂肪变性和纤维化的脂肪性肝炎。根据非酒精性脂肪性肝病(NAFLD)活动评分系统,最大NAS评分在8 - 9周后出现(NAS评分:6.75)。遵循该方案还导致NASH组血清AST、ALT、总胆固醇和总甘油三酯水平显著升高。
与类似研究相比,采用基于高脂肪、胆固醇和蔗糖并结合CCl4注射的特殊营养方案,可在更短时间内使用C57BL/6J小鼠建立NASH模型。所获得的组织病理学NASH特征对临床前药物测试可能具有优势。